Heterogeneous expression of cell-surface antigens in normal epithelia and their tumours, revealed by monoclonal antibodies.

PubWeight™: 1.42‹?› | Rank: Top 5%

🔗 View Article (PMC 1977033)

Published in Br J Cancer on February 01, 1985

Authors

P A Edwards

Articles citing this

Epithelial glycoprotein is a member of a family of epithelial cell surface antigens homologous to nidogen, a matrix adhesion protein. Proc Natl Acad Sci U S A (1990) 1.72

Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelial. J Clin Pathol (1990) 1.60

Near IR heptamethine cyanine dye-mediated cancer imaging. Clin Cancer Res (2010) 1.44

Epithelium-specific surface glycoprotein of Mr 34,000 is a widely distributed human carcinoma marker. Br J Cancer (1987) 1.30

Antigenicity of newly established colorectal carcinoma cell lines. Br J Cancer (1986) 1.00

Tumor markers in the human ovary and its neoplasms. A comparative immunohistochemical study. Am J Pathol (1987) 0.99

Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer. Br J Cancer (1990) 0.96

Localisation of monoclonal antibodies reacting with different epitopes on carcinoembryonic antigen (CEA)--implications for targeted therapy. Br J Cancer (1994) 0.92

Comparative study of carcinoembryonic antigen and epithelial membrane antigen expression in normal colon, adenomas and adenocarcinomas of the colon and rectum. Gut (1989) 0.88

Immunological analysis of the specificity of the autologous humoral response in breast cancer patients. Br J Cancer (1986) 0.86

Near-infrared fluorescence imaging of cancer mediated by tumor hypoxia and HIF1α/OATPs signaling axis. Biomaterials (2014) 0.82

Near-infrared fluorescence and nuclear imaging and targeting of prostate cancer. Transl Androl Urol (2013) 0.81

Cell surface antigens of human trophoblast: definition of an apparently unique system with a monoclonal antibody. Immunology (1986) 0.80

Radioimmunotherapy of malignancy using antibody targeted radionuclides. Br J Cancer (1986) 0.79

Antigenic heterogeneity and individuality in adenocarcinomas of the rectum and their secondaries. Br J Cancer (1987) 0.79

Primary polyoma virus-induced murine thymic epithelial tumors. A tumor model of thymus physiology. Am J Pathol (1989) 0.79

Targeting enzymes for cancer therapy: old enzymes in new roles. Br J Cancer (1994) 0.79

Optical imaging of gastric cancer with near-infrared heptamethine carbocyanine fluorescence dyes. Oncotarget (2016) 0.77

Biodistribution of a radiolabelled monoclonal antibody NY3D11 recognizing the neural cell adhesion molecule in tumour xenografts and patients with small-cell lung cancer. Br J Cancer (1998) 0.75

Deficient expression of MHC class II antigens in some cases of human B cell leukaemia. Clin Exp Immunol (1986) 0.75

Cellular localisation of tumour antigen (TA-4) in normal, dysplastic and neoplastic squamous epithelia of the upper aerodigestive tract. Br J Cancer (1990) 0.75

CD24 Expression Is Increased in 5-Fluorouracil-Treated Esophageal Adenocarcinoma Cells. Front Pharmacol (2017) 0.75

Articles cited by this

The clonal evolution of tumor cell populations. Science (1976) 24.39

Tumor heterogeneity. Cancer Res (1984) 6.17

The major histocompatibility complex of the mouse. Science (1979) 4.76

Biological diversity in metastatic neoplasms: origins and implications. Science (1982) 3.95

Graft-versus-host disease induces expression of Ia antigen in rat epidermal cells and gut epithelium. Nature (1981) 3.16

Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin. Cancer Res (1983) 3.15

Distribution of epithelial membrane antigen in normal and neoplastic tissues and it value in diagnostic tumor pathology. Cancer (1981) 3.07

GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody. J Exp Med (1982) 2.74

Expression of Ia antigen on epidermal keratinocytes in graft-versus-host disease. Nature (1981) 2.71

Complexity of expression of antigenic determinants, recognized by monoclonal antibodies HMFG-1 and HMFG-2, in normal and malignant human mammary epithelial cells. J Immunol (1983) 2.59

Differentiation antigens expressed by epithelial cells in the lactating breast are also detectable in breast cancers. Int J Cancer (1981) 2.53

Biological behavior of human breast carcinoma-associated antigens expressed during cellular proliferation. Cancer Res (1983) 2.46

A new marker for human cancer cells, 2 immunohistochemical detection of the Ca antigen in human tissues with the Ca1 antibody. Lancet (1982) 2.17

Monoclonal antibodies against human milk-fat globule membranes detecting differentiation antigens of the mammary gland and its tumors. Int J Cancer (1984) 2.12

A spectrum of monoclonal antibodies reactive with human mammary tumor cells. Proc Natl Acad Sci U S A (1981) 2.00

Tissue- and developmental stage-specific forms of a neural cell surface antigen linked to differences in glycosylation of a common polypeptide. EMBO J (1982) 1.92

Distribution of HLA class 1 antigens in normal human tissue and in mammary cancer. J Clin Pathol (1981) 1.87

A monoclonal antibody, NCRC-11, raised to human breast carcinoma. 1. Production and immunohistological characterization. Histopathology (1984) 1.72

Monoclonal antibodies to the human mammary gland. I. Distribution of determinants in non-neoplastic mammary and extra mammary tissues. Virchows Arch A Pathol Anat Histol (1982) 1.68

Monoclonal antibody to keratin filaments, specific for glandular epithelia and their tumors. Use in surgical pathology. Lab Invest (1983) 1.65

The prognostic significance of two epithelial membrane antigens expressed by human mammary carcinomas. Int J Cancer (1984) 1.61

Generation of monoclonal antibodies reacting with normal and cancer cells of human breast. Cancer Res (1983) 1.60

Monoclonal antibody to murine embryos defines a stage-specific embryonic antigen expressed on mouse embryos and human teratocarcinoma cells. Cell (1982) 1.59

Identification of a human neuroectodermal tumor antigen (OFA-I-2) as ganglioside GD2. Proc Natl Acad Sci U S A (1982) 1.54

Detection of cell surface and intracellular antigens by human monoclonal antibodies. Hybrid cell lines derived from lymphocytes of patients with malignant melanoma. J Exp Med (1983) 1.48

Monoclonal antibodies directed against the human Leb blood group antigen. J Biol Chem (1981) 1.38

Immunohistochemical localization of the mouse stage-specific embryonic antigen 1 in human tissues and tumors. Cancer Res (1983) 1.33

Mouse monoclonal antibody F-3 recognizes the difucosyl type-2 blood group structure. Immunogenetics (1983) 1.27

Phenotypic drift of metastatic and cell-surface properties of mammary adenocarcinoma cell clones during growth in vitro. Int J Cancer (1981) 1.26

Characterization of a human melanoma-associated ganglioside antigen defined by a monoclonal antibody, 4.2. J Biol Chem (1982) 1.25

Heterogeneity in the expression of HLA and tumor-associated antigens by surgically removed and cultured breast carcinoma cells. Cancer Res (1983) 1.25

Isolation and characterization of mucin-like glycoprotein in human milk fat globule membrane. J Biochem (1982) 1.24

Monoclonal antibodies and human tumor pathology. Hum Pathol (1982) 1.24

The membrane antigens of human colorectal cancer cells: demonstration with monoclonal antibodies of heterogeneity within and between tumours and of anomalous expression of HLA-DR. Eur J Cancer Clin Oncol (1983) 1.24

Cellular heterogeneity in tumours. Br J Cancer (1983) 1.23

Epithelial membrane antigen: partial purification, assay and properties. Br J Cancer (1983) 1.21

The monoclonal antibody directed to difucosylated type 2 chain (Fuc alpha 1 leads to 2Gal beta 1 leads to 4[Fuc alpha 1 leads to 3]GlcNAc; Y Determinant). J Biol Chem (1983) 1.20

Is heterogeneous expression of HLA-dr antigens and CEA along with DNA-profile variations evidence of phenotypic instability and clonal proliferation in human large bowel carcinomas? Br J Cancer (1983) 1.20

Neutral glycolipid antigens as developmental markers of mouse teratocarcinoma and early embryos: an immunologic and chemical analysis. J Immunol (1982) 1.19

Distribution of monoclonal antibody-defined monosialoganglioside in normal and cancerous human tissues: an immunoperoxidase study. Hybridoma (1983) 1.18

Immunochemical analysis of the determinant recognized by a monoclonal antibody (MBr1) which specifically binds to human mammary epithelial cells. Cancer Res (1983) 1.16

Atypical endocrine tumors of the lung. Arch Pathol Lab Med (1981) 1.15

Many monoclonal antibodies with an apparent specificity for certain lung cancers are directed against a sugar sequence found in lacto-N-fucopentaose III. Arch Biochem Biophys (1983) 1.09

Experimental systems for analysis of the malignant phenotype. Cancer Metastasis Rev (1982) 1.02

Implications of immunological heterogeneity of tumours. Nature (1979) 1.01

Differential cell adhesion may result from nonspecific interactions between cell surface glycoproteins. Nature (1978) 1.01

Preparation and identification of human breast epithelial cells in culture. Int J Cancer (1980) 1.00

Monoclonal antibodies to the human mammary gland. II. Distribution of determinants in breast carcinomas. Virchows Arch A Pathol Anat Histol (1982) 0.99

Relationship between antigen density and immunotherapeutic response elicited by monoclonal antibodies against solid tumors. J Natl Cancer Inst (1984) 0.96

Definition of antigenic heterogeneity and modulation among human mammary carcinoma cell populations using monoclonal antibodies to tumor-associated antigens. Cancer Res (1983) 0.95

Modulation of phenotype in cultures of human milk epithelial cells and its relation to the expression of a membrane antigen. Cell Differ (1983) 0.95

The presence of HLA-DR antigens on lactating human breast epithelium and milk fat globule membranes. Clin Exp Immunol (1980) 0.94

Expression of the OKT monoclonal antibody defined antigenic determinants in malignancy. Int J Immunopharmacol (1981) 0.92

Biological and clinical implications of lymphocyte hybridomas: tumor therapy with monoclonal antibodies. Annu Rev Med (1983) 0.92

Monoclonal antibody (F5) to human prostate antigen. Hybridoma (1983) 0.92

Reactivity spectrum of 30 monoclonal antimelanoma antibodies to a panel of 28 melanoma and control cell lines. Hybridoma (1982) 0.89

Two mouse hybridoma antibodies against human milk-fat globules recognise the I(Ma) antigenic determinant beta-D-Galp-(1 leads to 4)-beta-D-GlcpNAc-(1 leads to 6). Carbohydr Res (1983) 0.89

Do metastases arise from pre-existing subpopulations of cancer cells? Br J Cancer (1983) 0.89

The use of monoclonal antibodies for histopathologic diagnosis of human malignancy. Semin Oncol (1982) 0.88

Some properties and applications of monoclonal antibodies. Biochem J (1981) 0.88

Use of monoclonal antibodies in detection of melanoma-associated antigens in intact human tumors. Am J Pathol (1982) 0.87

Biology of disease. Monoclonal antibodies and tumor-associated antigens. Lab Invest (1983) 0.87

Heterogeneity of beta 2-microglobulin in human breast carcinoma. Lab Invest (1981) 0.86

Antigenic subsets of human breast epithelial cells distinguished by monoclonal antibodies. J Histochem Cytochem (1984) 0.84

Clonal analysis of morphological phenotype in cultured mammary epithelial cells from human milk. Proc R Soc Lond B Biol Sci (1982) 0.84

Immunohistochemical localization of prostate carcinoma-associated antigens. Cancer Res (1983) 0.82

Comparison of rates of phenotypic variability in surface antigen expression in normal and cancerous human breast epithelial cells. Cancer Res (1983) 0.82

Monoclonal antibody against A1 Lewis d antigen produced by the hybridoma immunized with a pulmonary carcinoma. Cancer Res (1982) 0.81

Production of human T-lymphocyte clones. I. monoclonal culture and functional cytotoxic maturation. J Immunol Methods (1981) 0.77

Articles by these authors

(truncated to the top 100)

A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol Cell (2001) 5.76

Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages. Proc Natl Acad Sci U S A (1980) 4.66

Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. Proc Natl Acad Sci U S A (2000) 4.58

Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation (1995) 3.82

Human white/murine ABC8 mRNA levels are highly induced in lipid-loaded macrophages. A transcriptional role for specific oxysterols. J Biol Chem (2000) 2.95

The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture. Arterioscler Thromb Vasc Biol (1996) 2.56

Identification of glycerol-3-phosphate acyltransferase as an adipocyte determination and differentiation factor 1- and sterol regulatory element-binding protein-responsive gene. J Biol Chem (1997) 2.36

Monoclonal antibodies to human erythrocytes. Eur J Immunol (1982) 2.24

Elucidation of the deficiency in two yeast coenzyme Q mutants. Characterization of the structural gene encoding hexaprenyl pyrophosphate synthetase. J Biol Chem (1990) 2.19

A human-hybridoma system based on a fast-growing mutant of the ARH-77 plasma cell leukemia-derived line. Eur J Immunol (1982) 2.17

Specificity of receptor-mediated recognition of malondialdehyde-modified low density lipoproteins. Proc Natl Acad Sci U S A (1982) 2.04

The metabolism of native and malondialdehyde-altered low density lipoproteins by human monocyte-macrophages. J Lipid Res (1981) 1.97

Spectral karyotyping suggests additional subsets of colorectal cancers characterized by pattern of chromosome rearrangement. Proc Natl Acad Sci U S A (2001) 1.85

Effect of site-directed mutagenesis of conserved aspartate and arginine residues upon farnesyl diphosphate synthase activity. J Biol Chem (1993) 1.83

Identification of the DNA binding specificity and potential target genes for the farnesoid X-activated receptor. J Biol Chem (2000) 1.75

Factors regulating the activities of the low density lipoprotein receptor and the scavenger receptor on human monocyte-macrophages. J Lipid Res (1981) 1.73

Sterol regulatory element binding protein binds to a cis element in the promoter of the farnesyl diphosphate synthase gene. Proc Natl Acad Sci U S A (1996) 1.71

Monoclonal antibodies to the human mammary gland. I. Distribution of determinants in non-neoplastic mammary and extra mammary tissues. Virchows Arch A Pathol Anat Histol (1982) 1.68

Integrin-linked kinase regulates phosphorylation of serine 473 of protein kinase B by an indirect mechanism. Oncogene (1999) 1.67

Ameloblastic carcinoma: a clinicopathologic study and assessment of eight cases. Oral Surg Oral Med Oral Pathol (1987) 1.66

Farnesoid X-activated receptor induces apolipoprotein C-II transcription: a molecular mechanism linking plasma triglyceride levels to bile acids. Mol Endocrinol (2001) 1.66

COQ2 is a candidate for the structural gene encoding para-hydroxybenzoate:polyprenyltransferase. J Biol Chem (1992) 1.57

The role of lipoproteins and receptor-mediated endocytosis in the transport of bacterial lipopolysaccharide. Proc Natl Acad Sci U S A (1986) 1.54

Characterization of the human ABCG1 gene: liver X receptor activates an internal promoter that produces a novel transcript encoding an alternative form of the protein. J Biol Chem (2001) 1.53

Mevalonolactone inhibits the rate of synthesis and enhances the rate of degradation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in rat hepatocytes. J Biol Chem (1983) 1.51

In vivo demonstration of the circadian thythm of cholesterol biosynthesis in the liver and intestine of the rat. J Lipid Res (1972) 1.50

Identification of conserved cis-elements and transcription factors required for sterol-regulated transcription of stearoyl-CoA desaturase 1 and 2. J Biol Chem (1999) 1.47

Molecular cloning and sequence of a cholesterol-repressible enzyme related to prenyltransferase in the isoprene biosynthetic pathway. Mol Cell Biol (1987) 1.46

Necrotizing sialometaplasia: literature review and case reports. J Am Dent Assoc (1996) 1.45

Alterations in the rates of synthesis and degradation of rat liver 3-hydroxy-3-methylglutaryl coenzyme A reductase produced by cholestyramine and mevinolin. J Biol Chem (1983) 1.43

Monoclonal antibodies that bind to the human erythrocyte-membrane glycoproteins glycophorin A and Band 3 [proceedings]. Biochem Soc Trans (1980) 1.42

Separation of and cholesterol synthesis by human lymphocytes and monocytes. J Lipid Res (1979) 1.40

Molecular cytogenetic analysis of breast cancer cell lines. Br J Cancer (2000) 1.36

Properties of purified rat hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase and regulation of enzyme activity. J Biol Chem (1980) 1.35

Effects of site-directed mutagenesis of the highly conserved aspartate residues in domain II of farnesyl diphosphate synthase activity. J Biol Chem (1992) 1.35

The association of posterior capsular lens opacities with bilateral acoustic neuromas in patients with neurofibromatosis type 2. Arch Ophthalmol (1989) 1.34

Properties of aqueous dispersions of phospholipid and cholesterol. Eur J Biochem (1968) 1.32

Inactivation of bacteriophage T7 by mono- and difunctional sulphur mustards in relation to cross-linking and depurination of bacteriophage DNA. J Mol Biol (1969) 1.32

Control of 3-hydroxy-3-methylglutaryl coenzyme A reductase by endogenously synthesized sterols in vitro and in vivo. J Biol Chem (1977) 1.30

Continuous lumbar epidural analgesia using bupivicaine: a study of the fetus and newborn child. J Obstet Gynaecol Br Commonw (1971) 1.29

Identification of farnesol as the non-sterol derivative of mevalonic acid required for the accelerated degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J Biol Chem (1994) 1.29

Growth retardation in asthmatic children treated with inhaled beclomethasone dipropionate. Lancet (1988) 1.29

Wnt-4 expression induces a pregnancy-like growth pattern in reconstituted mammary glands in virgin mice. Dev Biol (1995) 1.28

Impaired mammary gland development in Cyl-1(-/-) mice during pregnancy and lactation is epithelial cell autonomous. Dev Biol (1999) 1.27

Synergistic binding of sterol regulatory element-binding protein and NF-Y to the farnesyl diphosphate synthase promoter is critical for sterol-regulated expression of the gene. J Biol Chem (1996) 1.26

Localization of 3-hydroxy-3-methylglutaryl CoA reductase and 3-hydroxy-3-methylglutaryl CoA synthase in the rat liver and intestine is affected by cholestyramine and mevinolin. J Lipid Res (1988) 1.24

Determination of mevalonate in blood plasma in man and rat. Mevalonate "tolerance" tests in man. J Lipid Res (1979) 1.20

The low concentration of macroglobulin antibodies in peripheral lymph. Immunology (1969) 1.19

Diurnal rhythm of rat liver mRNAs encoding 3-hydroxy-3-methylglutaryl coenzyme A reductase. Correlation of functional and total mRNA levels with enzyme activity and protein. J Biol Chem (1984) 1.14

Transcriptional activation of the stearoyl-CoA desaturase 2 gene by sterol regulatory element-binding protein/adipocyte determination and differentiation factor 1. J Biol Chem (1998) 1.12

Synergistic activation of transcription by nuclear factor Y and sterol regulatory element binding protein. J Lipid Res (1998) 1.12

Retroviral expression of Wnt-1 and Wnt-7b produces different effects in mouse mammary epithelium. J Cell Sci (2000) 1.12

Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase mRNA levels in rat liver. Proc Natl Acad Sci U S A (1983) 1.10

Bacterial endotoxin selectively prevents the expression of scavenger-receptor activity on human monocyte-macrophages. J Immunol (1985) 1.09

Mechanism of induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase in human leukocytes. J Biol Chem (1977) 1.09

Molecular cloning and promoter analysis of the rat liver farnesyl diphosphate synthase gene. J Biol Chem (1992) 1.09

LDL, scavenger, and beta-VLDL receptors on aortic endothelial cells. Arteriosclerosis (1984) 1.08

Cholesterol biosynthesis in human lymphocytes, monocytes, and granulocytes. Biochem Biophys Res Commun (1977) 1.07

Radioimmune precipitation of 3-hydroxy-3-methylglutaryl coenzyme A reductase from Chinese hamster fibroblasts. Effect of 25-hydroxycholesterol. J Biol Chem (1981) 1.07

Expression of cell-surface HLA-DR, HLA-ABC and glycophorin during erythroid differentiation. Nature (1981) 1.07

The effect of cholestyramine and Mevinolin on the diurnal cycle of rat hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase. J Lipid Res (1982) 1.06

NF-Y has a novel role in sterol-dependent transcription of two cholesterogenic genes. J Biol Chem (1995) 1.06

The regulation of acetoacetyl-CoA synthetase activity by modulators of cholesterol synthesis in vivo and the utilization of acetoacetate for cholesterogenesis. J Biol Chem (1984) 1.04

CBP is required for sterol-regulated and sterol regulatory element-binding protein-regulated transcription. J Biol Chem (1998) 1.04

Carcinocythemia (carcinoma cell leukemia) due to metastatic carcinoma of the breast: report of a case. Cancer (1977) 1.03

Farnesyl-diphosphate synthase is localized in peroxisomes. J Biol Chem (1994) 1.03

Rabbit beta-migrating very low density lipoprotein increases endothelial macromolecular transport without altering electrical resistance. J Clin Invest (1986) 1.02

Differential cell adhesion may result from nonspecific interactions between cell surface glycoproteins. Nature (1978) 1.01

Identification and regulation of a rat liver cDNA encoding farnesyl pyrophosphate synthetase. J Biol Chem (1989) 1.01

Regulation of the uptake and degradation of beta-very low density lipoprotein in human monocyte macrophages. J Biol Chem (1983) 1.00

Testis-specific transcription initiation sites of rat farnesyl pyrophosphate synthetase mRNA. Mol Cell Biol (1990) 1.00

Pathogenesis of atherosclerosis. Am J Cardiol (1995) 0.99

Monoclonal antibodies to the human mammary gland. II. Distribution of determinants in breast carcinomas. Virchows Arch A Pathol Anat Histol (1982) 0.99

Macrophage lipoprotein receptors. J Cell Sci Suppl (1988) 0.98

Transcriptional regulation of the 3-hydroxy-3-methylglutaryl coenzyme A reductase gene in rat liver. J Biol Chem (1985) 0.98

Alterations of the growth characteristics of the fibroblast cell line C3H 10T1/2 by members of the Wnt gene family. Oncogene (1994) 0.97

Lymphocyte-conditioned medium protects human monocyte-macrophages from cholesteryl ester accumulation. Proc Natl Acad Sci U S A (1982) 0.97

Isolation and sequence of the human farnesyl pyrophosphate synthetase cDNA. Coordinate regulation of the mRNAs for farnesyl pyrophosphate synthetase, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and 3-hydroxy-3-methylglutaryl coenzyme A synthase by phorbol ester. J Biol Chem (1990) 0.96

Aging studies on normal lens using the Scheimpflug slit-lamp camera. Invest Ophthalmol Vis Sci (1993) 0.96

Dependence of the circadian rhythm of hepatic beta-hydroxy-beta-methylglutaryl coenzyme A on ribonucleic acid synthesis. A possible second site of inhibition by dietary cholesterol. J Biol Chem (1974) 0.96

The action of mono- and di-functional sulphur mustards on the ribonucleic acid-containing bacteriophage mu2. Biochem J (1971) 0.96

Receptor-mediated uptake of remnant lipoproteins by cholesterol-loaded human monocyte-macrophages. J Biol Chem (1985) 0.95

Selective culture of epithelioid cells from a human squamous carcinoma using a monoclonal antibody to kill fibroblasts. Cell Biol Int Rep (1980) 0.95

Is mucus a selective barrier to macromolecules? Br Med Bull (1978) 0.95

Non-random chromosomal rearrangements in pancreatic cancer cell lines identified by spectral karyotyping. Int J Cancer (2001) 0.94

Improved methods for the solubilization and assay of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase. J Lipid Res (1979) 0.94

Cytogenetic analysis of three breast carcinoma cell lines using reverse chromosome painting. Genes Chromosomes Cancer (1997) 0.93

Lymphokines secreted by an established lymphocyte line modulate receptor-mediated endocytosis in macrophages derived from human monocytes. J Immunol (1983) 0.93

Mevalonic acid-dependent degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in vivo and in vitro. J Biol Chem (1994) 0.92

Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in avian myeloblasts. Mode of action of 25-hydroxycholesterol. J Biol Chem (1983) 0.92

Effect of adrenalectomy and hypophysectomy on the circadian rhythm of -hydroxy- -methylglutaryl coenzyme A reductase activity in rat liver. J Biol Chem (1973) 0.91

Signaling molecules derived from the cholesterol biosynthetic pathway. Subcell Biochem (1997) 0.91

Effect of plasma lipoproteins and lecithin-cholesterol dispersions on the activity of 3-hydroxy-3-methylglutaryl-coenzyme A reductase of isolated rat hepatocytes. Biochim Biophys Acta (1975) 0.91

The influence of catecholamines and cyclic AMP on 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and lipid biosynthesis in isolated rat hepatocytes. Arch Biochem Biophys (1975) 0.91

Analysis of regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in a somatic cell mutant auxotrophic for mevalonate. J Biol Chem (1982) 0.91

The inactivation by fluorodinitrobenzene of glucose transport across the human erythrocyte membrane. The effect of glucose inside or outside the cell. Biochim Biophys Acta (1973) 0.90

Human geranylgeranyl diphosphate synthase: isolation of the cDNA, chromosomal mapping and tissue expression. J Lipid Res (1998) 0.90

Functional size of rat hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase as determined by radiation inactivation. J Biol Chem (1985) 0.89

Two mouse hybridoma antibodies against human milk-fat globules recognise the I(Ma) antigenic determinant beta-D-Galp-(1 leads to 4)-beta-D-GlcpNAc-(1 leads to 6). Carbohydr Res (1983) 0.89

Fibromatosis colli: a case report. Otolaryngol Head Neck Surg (1979) (1980) 0.89